Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Aug;12(4):3195-3199.
doi: 10.1002/ehf2.15283. Epub 2025 Apr 8.

Pantethine therapy dramatically rescues end-stage failing heart in a patient with deficiency of coenzyme A biosynthesis

Affiliations
Case Reports

Pantethine therapy dramatically rescues end-stage failing heart in a patient with deficiency of coenzyme A biosynthesis

Violette Goetz et al. ESC Heart Fail. 2025 Aug.
No abstract available

Keywords: Metabolic therapy; PPCS deficiency; Vitamin B5 (pantothenate).

PubMed Disclaimer

Conflict of interest statement

FL reports consulting fees from AlfaSigma, Biomarin and Sanofi Genzyme, outside the submitted work. The other authors reported no conflict of interest.

Figures

Figure 1
Figure 1
Ultrastructural alterations in muscle mitochondria from an infant with PPCS deficiency. Representative transmission electron microscopy (TEM) images revealed the presence of degenerative mitochondria (white arrowheads) with altered matrix and/or poorly preserved mitochondrial cristae. Scale bar: 1 μm.
Figure 2
Figure 2
Improvement of cardiac function with pantethine therapy in an infant with severe PPCS deficiency. Long‐term follow‐up of (A) left ventricular end‐diastolic diameter (LVEDD, expressed in SD for body area), (B) left ventricular ejection fraction (LVEF, %) and (C) NT‐ProBNP blood levels, before and during pantethine therapy (28 mg/kg/day). Normal ranges are in green. Long axis M mode of left ventricle before (D) and 6 months after introduction of panthetine (E) showing the normalization of systolic left ventricle function (LV shortening fraction improved from 20% to 45%).
Figure 3
Figure 3
The CoA biosynthetic pathway from vitamin B5 and the salvage pathway from pantethine. DPCK, dephospho‐CoA kinase; PANK, pantothenate kinase; PPAT, phosphopantetheine adenylyltransferase; PPCDC, phosphopantothenoylcysteine decarboxylase; PPCS, phosphopantothenoylcysteine synthetase.

References

    1. Leonardi R, Zhang YM, Rock CO, Jackowski S. Coenzyme A: back in action. Prog Lipid Res 2005;44:125–153. doi: 10.1016/j.plipres.2005.04.001 - DOI - PubMed
    1. Sibon OC, Strauss E. Coenzyme A: to make it or uptake it? Nat Rev Mol Cell Biol 2016;17:605–606. doi: 10.1038/nrm.2016.110 - DOI - PubMed
    1. Iuso A, Wiersma M, Schüller HJ, Pode‐Shakked B, Marek‐Yagel D, Grigat M, et al.Mutations in PPCS, encoding phosphopantothenoylcysteine synthetase, cause autosomal‐recessive dilated cardiomyopathy. Am J Hum Genet. 2018;102:1018–1030. doi: 10.1016/j.ajhg.2018.03.022 - DOI - PMC - PubMed
    1. Srinivasan B, Baratashvili M, van der Zwaag M, Kanon B, Colombelli C, Lambrechts RA, et al. Extracellular 4′‐phosphopantetheine is a source for intracellular coenzyme A synthesis. Nat Chem Biol 2015;11:784–792. doi: 10.1038/nchembio.1906 - DOI - PubMed
    1. Lok A, Fernandez‐Garcia MA, Taylor RW, French C, MacFarland R, Bodi I, et al. Novel phosphopantothenoylcysteine synthetase (PPCS) mutations with prominent neuromuscular features: expanding the phenotypical spectrum of PPCS‐related disorders. Am J Med Genet A 2022;188:2783–2789. doi: 10.1002/ajmg.a.62848 - DOI - PubMed

Publication types

LinkOut - more resources